{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T23:53:00Z","timestamp":1781481180264,"version":"3.54.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82102788"],"award-info":[{"award-number":["82102788"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Outstanding Scientific Research and Innovation Team for Male Genitourinary Diseases in Anhui Provincial Universities","award":["2022AH010071"],"award-info":[{"award-number":["2022AH010071"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-49569-x","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T08:37:57Z","timestamp":1776760677000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A novel nomogram incorporating lymphovascular invasion to predict lymph node invasion in high-risk prostate cancer"],"prefix":"10.1038","volume":"16","author":[{"given":"Yige","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuiping","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,21]]},"reference":[{"key":"49569_CR1","first-page":"10","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel, R. L., Kratzer, T. B., Giaquinto, A. N., Sung, H. & Jemal, A. Cancer statistics, 2025. CA Cancer J. Clin. 75, 10\u201345 (2025).","journal-title":"CA Cancer J. Clin."},{"key":"49569_CR2","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.eururo.2024.04.010","volume":"86","author":"D Tilki","year":"2024","unstructured":"Tilki, D. et al. EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer: Part II-2024 update\u2014treatment of relapsing and metastatic prostate cancer. Eur. Urol. 86, 164\u2013182 (2024).","journal-title":"Eur. Urol."},{"key":"49569_CR3","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.eururo.2016.12.003","volume":"72","author":"N Fossati","year":"2017","unstructured":"Fossati, N. et al. The benefits and harms of different extents of lymph node dissection during radical prostatectomy for prostate cancer: A systematic review. Eur. Urol. 72, 84\u2013109 (2017).","journal-title":"Eur. Urol."},{"key":"49569_CR4","doi-asserted-by":"crossref","unstructured":"Incesu, R. B. et al. Negative PSMA PET can be used to avoid unnecessary pelvic lymph node dissection in intermediate risk prostate cancer. Prostate Cancer Prostatic Dis. 28, 874\u2013878 (2025).","DOI":"10.1038\/s41391-024-00930-z"},{"key":"49569_CR5","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.eururo.2017.03.049","volume":"72","author":"G Gandaglia","year":"2017","unstructured":"Gandaglia, G. et al. Development and internal validation of a novel model to identify the candidates for extended pelvic lymph node dissection in prostate cancer. Eur. Urol. 72, 632\u2013640 (2017).","journal-title":"Eur. Urol."},{"key":"49569_CR6","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.urology.2015.12.054","volume":"91","author":"AJ Vickers","year":"2016","unstructured":"Vickers, A. J., Eastham, J. A., Scardino, P. T. & Lilja, H. The memorial sloan kettering cancer center recommendations for prostate cancer screening. Urology 91, 12\u201318 (2016).","journal-title":"Urology"},{"key":"49569_CR7","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.eururo.2022.07.002","volume":"82","author":"GJ Netto","year":"2022","unstructured":"Netto, G. J. et al. The 2022 World Health Organization classification of tumors of the urinary system and male genital organs-part B: Prostate and urinary tract tumors. Eur. Urol. 82, 469\u2013482 (2022).","journal-title":"Eur. Urol."},{"key":"49569_CR8","doi-asserted-by":"crossref","unstructured":"Magi-Galluzzi, C. et al. International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens: Working group 3\u2014extraprostatic extension, lymphovascular invasion and locally advanced disease. Mod Pathol 24, 26\u201338 (2011).","DOI":"10.1038\/modpathol.2010.158"},{"key":"49569_CR9","doi-asserted-by":"crossref","unstructured":"Karwacki, J. et al. Preoperative factors for lymphovascular invasion in prostate cancer: A systematic review and meta-analysis. Int J. Mol. Sci. 25, 856 (2024).","DOI":"10.3390\/ijms25020856"},{"key":"49569_CR10","doi-asserted-by":"publisher","first-page":"780","DOI":"10.4103\/1008-682X.156636","volume":"18","author":"Y Huang","year":"2016","unstructured":"Huang, Y. et al. The prognostic value of lymphovascular invasion in radical prostatectomy: a systematic review and meta-analysis. Asian J. Androl. 18, 780\u2013785 (2016).","journal-title":"Asian J. Androl."},{"key":"49569_CR11","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.eururo.2016.05.008","volume":"71","author":"G Gandaglia","year":"2017","unstructured":"Gandaglia, G. et al. Robot-assisted radical prostatectomy and extended pelvic lymph node dissection in patients with locally-advanced prostate cancer. Eur. Urol. 71, 249\u2013256 (2017).","journal-title":"Eur. Urol."},{"key":"49569_CR12","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.eururo.2015.06.046","volume":"69","author":"JI Epstein","year":"2016","unstructured":"Epstein, J. I. et al. A contemporary prostate cancer grading system: A validated alternative to the gleason score. Eur. Urol. 69, 428\u2013435 (2016).","journal-title":"Eur. Urol."},{"key":"49569_CR13","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1097\/MOU.0000000000000320","volume":"26","author":"C Magi-Galluzzi","year":"2016","unstructured":"Magi-Galluzzi, C., Montironi, R. & Epstein, J. I. Contemporary Gleason grading and novel Grade Groups in clinical practice. Curr. Opin. Urol. 26, 488\u2013492 (2016).","journal-title":"Curr. Opin. Urol."},{"key":"49569_CR14","unstructured":"Center. MSKc. dynamic prostate cancer nomogram: coefficients. https:\/\/www.mskcc.org\/nomograms\/prostate\/pre-op\/coefficients."},{"key":"49569_CR15","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.eururo.2011.10.044","volume":"61","author":"A Briganti","year":"2012","unstructured":"Briganti, A. et al. Updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection: the essential importance of percentage of positive cores. Eur. Urol. 61, 480\u2013487 (2012).","journal-title":"Eur. Urol."},{"key":"49569_CR16","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1016\/j.urology.2008.05.045","volume":"72","author":"P Pepe","year":"2008","unstructured":"Pepe, P. et al. Is quantitative histologic examination useful to predict nonorgan-confined prostate cancer when saturation biopsy is performed? Urology 72, 1198\u20131202 (2008).","journal-title":"Urology"},{"key":"49569_CR17","doi-asserted-by":"publisher","first-page":"1349536","DOI":"10.3389\/fonc.2024.1349536","volume":"14","author":"J Karwacki","year":"2024","unstructured":"Karwacki, J. et al. The clinical meaning of lymphovascular invasion: preoperative predictors and postoperative implications in prostate cancer - a retrospective study. Front. Oncol. 14, 1349536 (2024).","journal-title":"Front. Oncol."},{"key":"49569_CR18","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1245\/s10434-023-14691-x","volume":"31","author":"M Kawase","year":"2024","unstructured":"Kawase, M. et al. Prognostic importance of lymphovascular invasion for specific subgroup of patients with prostate cancer after robot-assisted radical prostatectomy (The MSUG94 Group). Ann. Surg. Oncol. 31, 2154\u20132162 (2024).","journal-title":"Ann. Surg. Oncol."},{"key":"49569_CR19","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1016\/j.eururo.2009.03.012","volume":"55","author":"A Briganti","year":"2009","unstructured":"Briganti, A. et al. Pelvic lymph node dissection in prostate cancer. Eur. Urol. 55, 1251\u20131265 (2009).","journal-title":"Eur. Urol."},{"key":"49569_CR20","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.euo.2021.02.001","volume":"4","author":"GE Cacciamani","year":"2021","unstructured":"Cacciamani, G. E. et al. Impact of pelvic lymph node dissection and its extent on perioperative morbidity in patients undergoing radical prostatectomy for prostate cancer: A comprehensive systematic review and meta-analysis. Eur. Urol. Oncol. 4, 134\u2013149 (2021).","journal-title":"Eur. Urol. Oncol."},{"key":"49569_CR21","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.21873\/anticanres.15621","volume":"42","author":"P Pepe","year":"2022","unstructured":"Pepe, P. & Pennisi, M. Should 68Ga-PSMA PET\/CT Replace CT and Bone Scan in Clinical Staging of High-risk Prostate Cancer? Anticancer Res. 42, 1495\u20131498 (2022).","journal-title":"Anticancer Res."},{"key":"49569_CR22","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1016\/j.eururo.2011.11.008","volume":"61","author":"A Briganti","year":"2012","unstructured":"Briganti, A. et al. Performance characteristics of computed tomography in detecting lymph node metastases in contemporary patients with prostate cancer treated with extended pelvic lymph node dissection. Eur. Urol. 61, 1132\u20131138 (2012).","journal-title":"Eur. Urol."},{"key":"49569_CR23","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.euo.2020.06.012","volume":"4","author":"M Anttinen","year":"2021","unstructured":"Anttinen, M. et al. A Prospective Comparison of (18)F-prostate-specific membrane Antigen-1007 positron emission tomography computed tomography, whole-body 1.5 T magnetic resonance imaging with diffusion-weighted imaging, and single-photon emission computed tomography\/computed tomography with traditional imaging in primary distant metastasis staging of prostate cancer (PROSTAGE). Eur. Urol. Oncol. 4, 635\u2013644 (2021).","journal-title":"Eur. Urol. Oncol."},{"key":"49569_CR24","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.euo.2020.08.012","volume":"5","author":"AT Lenis","year":"2022","unstructured":"Lenis, A. T. et al. Prostate-specific membrane antigen positron emission tomography\/computed tomography compared with conventional imaging for initial staging of treatment-na\u00efve intermediate- and high-risk prostate cancer: A retrospective single-center study. Eur. Urol. Oncol. 5, 544\u2013552 (2022).","journal-title":"Eur. Urol. Oncol."},{"key":"49569_CR25","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.eururo.2018.10.012","volume":"75","author":"G Gandaglia","year":"2019","unstructured":"Gandaglia, G. et al. A novel nomogram to identify candidates for extended pelvic lymph node dissection among patients with clinically localized prostate cancer diagnosed with magnetic resonance imaging-targeted and systematic biopsies. Eur. Urol. 75, 506\u2013514 (2019).","journal-title":"Eur. Urol."},{"key":"49569_CR26","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1245\/s10434-017-6238-z","volume":"25","author":"AD Newton","year":"2018","unstructured":"Newton, A. D. et al. Surgical management of early-stage esophageal adenocarcinoma based on lymph node metastasis risk. Ann. Surg. Oncol. 25, 318\u2013325 (2018).","journal-title":"Ann. Surg. Oncol."},{"key":"49569_CR27","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/bju.15134","volume":"127","author":"A Franklin","year":"2021","unstructured":"Franklin, A. et al. Histological comparison between predictive value of preoperative 3-T multiparametric MRI and (68) Ga-PSMA PET\/CT scan for pathological outcomes at radical prostatectomy and pelvic lymph node dissection for prostate cancer. BJU Int. 127, 71\u201379 (2021).","journal-title":"BJU Int."},{"key":"49569_CR28","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/S0140-6736(20)30314-7","volume":"395","author":"MS Hofman","year":"2020","unstructured":"Hofman, M. S. et al. Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study. Lancet 395, 1208\u20131216 (2020).","journal-title":"Lancet"},{"key":"49569_CR29","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1097\/JU.0000000000001592","volume":"205","author":"D Meijer","year":"2021","unstructured":"Meijer, D. et al. The predictive value of preoperative negative prostate specific membrane antigen positron emission tomography imaging for lymph node metastatic prostate cancer. J. Urol. 205, 1655\u20131662 (2021).","journal-title":"J. Urol."},{"key":"49569_CR30","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1097\/JU.0000000000001596","volume":"205","author":"T Amiel","year":"2021","unstructured":"Amiel, T. et al. Regional lymph node metastasis on prostate specific membrane antigen positron emission tomography correlates with decreased biochemical recurrence-free and therapy-free survival after radical prostatectomy: A retrospective single-center single-arm observational study. J. Urol. 205, 1663\u20131670 (2021).","journal-title":"J. Urol."},{"key":"49569_CR31","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1097\/JU.0000000000001697","volume":"206","author":"J Linxweiler","year":"2021","unstructured":"Linxweiler, J. et al. Robotic salvage lymph node dissection in recurrent prostate cancer: Lessons learned from 68 cases and implications for future clinical management. J. Urol. 206, 88\u201396 (2021).","journal-title":"J. Urol."},{"key":"49569_CR32","unstructured":"Gandaglia, G. et al. External validation of nomograms for the identification of pelvic nodal dissection candidates among prostate cancer patients with negative preoperative prostate-specific membrane antigen positron emission tomography. Eur Urol. Oncol (2025)."},{"key":"49569_CR33","doi-asserted-by":"publisher","first-page":"12132","DOI":"10.4081\/aiua.2024.12132","volume":"96","author":"P Pepe","year":"2024","unstructured":"Pepe, P., Pepe, L., Curduman, M., Pennisi, M. & Fraggetta, F. Ductal prostate cancer staging: Role of PSMA PET\/CT. Arch. Ital. Urol. Androl. 96, 12132 (2024).","journal-title":"Arch. Ital. Urol. Androl."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49569-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49569-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49569-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T23:23:05Z","timestamp":1781479385000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49569-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,21]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["49569"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-49569-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8486253\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,21]]},"assertion":[{"value":"31 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Ethics Committee of The First Affiliated Hospital of Anhui Medical University on March 26, 2025 (PJ-2025-01-42). Written informed consent was obtained from all participants in accordance with institutional and national research guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"18447"}}